Verona Pharma (VRP)

 

Latest News

Holding(s) in Company

RNS Number: 2914G Verona Pharma PLC 25 May 2017 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii Verona Pharma PLC 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights An acquisi...

Verona Pharma Announces Further Exercise of Over-Allotment Option and Resulting Total Voting Rights

Verona Pharma Announces Further Exercise of Over-Allotment Option and Resulting Total Voting Rights THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION (EU) NO 596/2014 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO OR FROM ...

Verona CEO to present at Jefferies Healthcare Conference

Verona Pharma has confirmed that Jan-Anders Karlsson, PhD, CEO of the Company, is scheduled to present at the Jeffer...

Verona Pharma to Present at Jefferies 2017 Global Healthcare Conference

Verona Pharma to Present at Jefferies 2017 Global Healthcare Conference May 23, 2017, LONDON - Verona Pharma plc (AIM:VRP) (NASDAQ:VRNA) ("Verona Pharma"), a clinical-stage biopharmaceutical company focused on developing and commercialising innovative therapeutics for the treatment of respiratory diseases with significant unmet medical needs, an...

All News

DateHeadlineSource
25-05-17Holding(s) in CompanyRNS
25-05-17Verona Pharma Announces Further Exercise of Over-Allotment Option and Resulting Total Voting RightsRNS
23-05-17Verona CEO to present at Jefferies Healthcare ConferenceStockMarketWire
23-05-17Verona Pharma to Present at Jefferies 2017 Global Healthcare ConferenceRNS
23-05-17Holding(s) in CompanyRNS
22-05-17Broker Forecast - Jefferies International issues a broker note on Verona Pharma PLCStockMarketWire
16-05-17Partial Exercise of Over-Allotment OptionRNS
08-05-17Holding(s) in CompanyRNS
05-05-17Holding(s) in CompanyRNS
05-05-17Holding(s) in CompanyRNS
05-05-17Holding(s) in CompanyRNS
03-05-17Holding(s) in CompanyRNS
03-05-17Block Listing Application and ReviewRNS
03-05-17Grant of Options and RSUs and PDMR DealingsRNS
02-05-17Closing of Global Offering and Total Voting RightsRNS
02-05-17Director/PDMR ShareholdingRNS
28-04-17Director Deals - Verona Pharma PLC (VRP)StockMarketWire
28-04-17Director/PDMR ShareholdingRNS
27-04-17Pricing of Offering and Approval to List on NASDAQRNS
19-04-17Global Offering and Application to List on NASDAQRNS
18-04-17FDA authorises start of Verona Pharma's US trialStockMarketWire
18-04-17FDA Authorisation to Proceed RPL554 InvestigationRNS
12-04-17All resolutions passed at Verona AGMStockMarketWire
12-04-17Result of AGMRNS
04-04-17Files Statement for Proposed Global OfferingRNS
04-04-17Files Statement for Proposed Global OfferingRNS
04-04-171st Patient Dosed in Ph2a Trial for RPL554 in CFRNS
03-04-17Board ChangeRNS
31-03-17COPD Collaboration and New Commercial DirectorRNS
22-03-17Verona Pharma in services agreement with QuintilesIMSStockMarketWire
22-03-17Services Agreement with QuintilesIMSRNS
20-03-17Verona Pharma schedules AGMStockMarketWire
20-03-17Posting of Annual report & Notice of AGMRNS
02-03-17Director Deals - Verona Pharma PLC (VRP)StockMarketWire
02-03-17PDMR DealingRNS
27-02-17Verona Pharma narrows FY pretax lossStockMarketWire
27-02-17Final ResultsRNS
23-02-17Notice of ResultsRNS
22-02-17First COPD patient dosed with RPL554RNS
08-02-17Verona share consolidation approved by shareholdersStockMarketWire

RSS feeds

  • Editorial news feed for LSE:VRP Editorial
  • Regulatory news feed for LSE:VRP Regulatory